Neochord Inc announced it raised $2 Million in an initial filing from an offering of $5.96 Million
09/22/22, 7:33 PM
Location
st. louis park
Money raised
$2 million
Industry
manufacturing
medical device
medical
biotechnology
health care
Round Type
seed
Company Info
Location
5402 parkdale drive, suite 160
st. louis park, minnesota, united states
Additional Info
NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company is dedicated to advancing the treatment of mitral regurgitation and developing innovative therapies for degenerative mitral valve disease.